Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
4 studies found for:    fxtas
Hide Display Options

Display Options

Study Details
Participant Details
Rank Status Study
1 Not yet recruiting Brain Network Activation and Gait and Posture in FXTAS
Conditions: Fragile X Associated Tremor-ataxia Syndrome;   FXTAS
2 Enrolling by invitation Treatment of Fragile-X Associated Tremor/Ataxia Syndrome (FXTAS) With Allopregnanolone
Condition: Fragile X-associated Tremor/Ataxia Syndrome
Intervention: Drug: Allopregnanolone
3 Unknown  Citocoline for Treatment of FXTAS
Condition: Balance and Cognitive Deficits in Fragile X-associated Tremor Ataxia Syndrome
Intervention: Drug: citocoline
4 Unknown  Memantine Treatment in Fragile X-Associated Tremor/Ataxia Syndrome
Conditions: Fragile X-Associated Tremor/Ataxia Syndrome;   Fragile X Premutation Carriers
Intervention: Drug: Memantine

Indicates status has not been verified in more than two years